GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanoEcho AB (publ) (OSTO:NANECH) » Definitions » ROCE %

NanoEcho AB (publ) (OSTO:NANECH) ROCE % : -69.39% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is NanoEcho AB (publ) ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NanoEcho AB (publ)'s annualized ROCE % for the quarter that ended in Dec. 2024 was -69.39%.


NanoEcho AB (publ) ROCE % Historical Data

The historical data trend for NanoEcho AB (publ)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoEcho AB (publ) ROCE % Chart

NanoEcho AB (publ) Annual Data
Trend Dec22 Dec23 Dec24
ROCE %
-116.08 -79.80 -75.22

NanoEcho AB (publ) Quarterly Data
Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
ROCE % Get a 7-Day Free Trial - -77.03 -78.06 -57.85 -69.39

NanoEcho AB (publ) ROCE % Calculation

NanoEcho AB (publ)'s annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-15.142/( ( (21.784 - 0) + (33.256 - 14.782) )/ 2 )
=-15.142/( (21.784+18.474)/ 2 )
=-15.142/20.129
=-75.22 %

NanoEcho AB (publ)'s ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=-14.036/( ( (24.582 - 2.6) + (33.256 - 14.782) )/ 2 )
=-14.036/( ( 21.982 + 18.474 )/ 2 )
=-14.036/20.228
=-69.39 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NanoEcho AB (publ)  (OSTO:NANECH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


NanoEcho AB (publ) ROCE % Related Terms

Thank you for viewing the detailed overview of NanoEcho AB (publ)'s ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoEcho AB (publ) Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 19, Lund, SWE, 223 63
NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.

NanoEcho AB (publ) Headlines

No Headlines